NRC Health (NRC) Insider John Nunnelly Buys 7,697 Shares

John Nunnelly recently purchased 7,697 shares of NRC Health, trading under the ticker NRC on the NasdaqGS. This transaction took place on June 23, 2026, although the price and value of the transaction were not specified. The acquisition was not part of a pre-planned trading program.

Insider Buying and Selling at NRC Health

Several insiders at NRC Health, including Lockhart Stephen, Parul Bhandari, Donald Berwick, Penny Ann Wheeler, and Jason Russell Rau, also made notable purchases. On the same day as Nunnelly, each of these insiders bought 7,697 shares. Earlier, on March 12, 2026, Jason Russell Rau, Executive Vice President, acquired 60,000 shares.

Other Institutional Activity in NRC Health

Among institutional investors, Kayne Anderson Rudnick Investment Management LLC reduced its holdings by 21,473 shares, now holding 2,636,355 shares worth about $44.8 million. Morgan Stanley also trimmed its position by 1,829 shares, leaving it with 1,001,880 shares valued at approximately $17 million. BlackRock, Inc. cut its stake by 29,468 shares, resulting in a total of 975,855 shares valued at $16.6 million. Vanguard Capital Management LLC opened a new position, acquiring 662,837 shares worth about $11.3 million. Meanwhile, Geode Capital Management, LLC increased its holdings by 10,336 shares, bringing its total to 393,847 shares valued at $6.7 million.

NRC Health Stock Down 0.7%

Shares of NRC Health, trading under the ticker NRC on NasdaqGS, were priced at $20.43 on Friday. The company, which provides healthcare analytics and insights, has a market capitalization of approximately $439.2 million. Its P/E ratio stands at 49.97, with a forward P/E of 16.80 and a beta of 0.399. Over the past year, NRC Health's stock has ranged from $11.01 to $22.79. The 50-day moving average is $18.40, and the 200-day moving average is $16.55. The company has a current ratio of 0.519 and a quick ratio of 0.362, with a debt-to-equity ratio of 578.229.

Analysts Set New Price Targets

On June 22, 2026, Citizens initiated coverage on NRC Health with a buy rating and set a price target of $23. The stock has an average analyst recommendation of "buy," with a mean price target of $23 based on multiple analyst opinions.

About NRC Health

NRC Health, headquartered in Lincoln, Nebraska, offers analytics and insights to improve patient and employee experiences for healthcare organizations in the U.S. The company, led by CEO Mr. Trent S. Green, provides solutions for market experience, patient experience, employee engagement, and consumer experience. Founded in 1981, NRC Health employs 357 people and was formerly known as National Research Corporation until April 2026.

Bottom Line

Insider buying at NRC Health, including John Nunnelly's recent acquisition, draws attention to the company's stock activity. With a solid market presence in healthcare analytics and a recent "buy" rating from Citizens, NRC Health remains a company to watch. As always, remember that insider transactions are reported after the fact and may not reflect current positions.